Karlheinz Peter

Atherothrombosis and Vascular Biology

BIOGRAPHY

Karlheinz Peter has not added Biography.

If you are Karlheinz Peter and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Mesoscale Nanoparticles: An Unexpected Means for Selective Therapeutic Targeting of Kidney Diseases!

Hypertension (Dallas, Tex. : 1979) 01, 2018 | Pubmed ID: 29133359

A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense.

Nature communications 02, 2018 | Pubmed ID: 29410422

Dual-Targeted Theranostic Delivery of miRs Arrests Abdominal Aortic Aneurysm Development.

Molecular therapy : the journal of the American Society of Gene Therapy 04, 2018 | Pubmed ID: 29525742

INSTITUTIONS

Baker Heart & Diabetes Institute

Monash University

JOVE ARTICLES

Tatjana Michel¹,

Antonia Link¹,

Meike-Kristin Abraham^1,2,

Christian Schlensak¹,

Karlheinz Peter^2,3,

Hans-Peter Wendel¹,

Xiaowei Wang^2,3,

Stefanie Krajewski¹

¹Department of Thoracic and Cardiovascular Surgery, Clinical Research Laboratory, University Medical Center,

²Atherothrombosis and Vascular Biology, Baker Heart & Diabetes Institute,

³Department of Medicine, Monash University

Bioengineering

Privacy

Policies

Recommend to library

JoVE NEWSLETTERS

Research

Education

Authors

Librarians

ABOUT JoVE